Pro Medicus (OTCMKTS:PMCUF) Stock Price Down 12.9% – What’s Next?

Shares of Pro Medicus Limited (OTCMKTS:PMCUF) fell 12.9% during trading on Thursday . The stock traded as low as $114.00 and last traded at $114.00. Approximately 186 shares changed hands during trading, a decline of 72% from the average session volume of 664 shares. The stock had previously closed at $130.92.

Analyst Ratings Changes

Separately, Jefferies Financial Group downgraded shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $155.00.

Pro Medicus Stock Performance

The stock has a market cap of $11.91 billion and a PE ratio of 9,666.67. The stock has a fifty day moving average price of $118.09 and a 200 day moving average price of $107.26.

About Pro Medicus

Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.